FFCD - Geriatric factors to predict toxicity and dose-intensity reduction in FFCD 2001-02 phase III study comparing a first-line chemotherapy of LV5FU2 or FOLFIRI in treatment of metastatic colorectal cancer (mCRC) in elderly patients

Geriatric factors to predict toxicity and dose-intensity reduction in FFCD 2001-02 phase III study comparing a first-line chemotherapy of LV5FU2 or FOLFIRI in treatment of metastatic colorectal cancer (mCRC) in elderly patients

Auteurs

T. Aparicio, J. L. Jouve, L. Teillet, D. Gargot, V. Le Brun Ly, J. Cretin, C. Locher, O. Bouche, G. Breysacher, J. Charneau, J. F. Seitz, M. Gasmi, F. Ricard, F. Subtil, E. Mitry

Journal / Conférence

ASCO

Type de publication

Abstract

Etude

FFCD 2001-02

Localisation

Colorectal